Implementation of IVS3 for Upper Limb Motor Recovery
Start Date
10/2/2024
Completion Date
6/1/2027
Summary
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Detailed Description
This study will investigate the implementation of the intensive visual stimulation three (IVS3) device in the outpatient rehabilitation setting. This is a phase I/II open label study that will assess participant satisfaction and upper extremity function in outpatients with chronic stroke (10 with hemi spatial neglect and 15 without), when exposed to IVS3 for 30 minutes and conventional treatment for 15 minutes, across 12 sessions in 4-6 weeks at Weill Cornell medicine outpatient rehabilitation (single site).
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Intensive Visual Stimulation Device
Conditions
Locations
Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106
New York, New York 10065
United States